You searched for
We found 9 articles
Study of Combination Thalidomide Plus Glucocorticoid Therapy Versus Glucocorticoid Therapy Alone as Induction Therapy for Previously Untreated Subjects with Multiple Myeloma
Randomized subjects will receive study drug, either thalidomide plus high-dose dexamethasone or placebo identical in appearance to thalidomide plus high-dose…
01 Jan 2013
A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older
Phase III randomised study to compare MPR with MP in newly diagnosed Multiple Myeloma subjects who are 65 years old…
01 Jan 2013
Bortezomib in Treating Patients With Newly Diagnosed High-Risk Stage III Multiple Myeloma
RATIONALE: Bortezomib may stop the growth of cancer cells by blocking the enzymes necessary for their growth. PURPOSE: This…
01 Jan 2013
Study to Determine the Effect and Safety of an Oral Janus Kinase 2 (JAK2)-Inhibitor in Patients with Multiple Myeloma
The purpose of this study is to determine clinical efficacy and safety of INCB018424, a small molecule Janus kinase (JAK)…
01 Jan 2013
Myeloma Foundation of Australia
Myeloma Foundation of Australia supports people living with myeloma, a form of cancer treated by bone marrow transplant and stem cell transplant.
25 Mar 2008
New Hope for Patients with Myeloma as Velcade is Added to the PBS
A novel therapy for advanced and progressive stages of multiple myeloma has become available on the Australian Pharmaceutical Benefits Scheme…
16 Nov 2007
New Hope for Patients with Myeloma as Velcade is Added to the PBS
An expensive drug for the treatment of advanced and progressive stages of multiple myeloma has become available on the Australian…
13 Nov 2007
Myeloma nephropathy
Myeloma nephropathy is a kidney disorder related to multiple myeloma, a cancer of the bone marrow. It causes excessive blood calcium or protein.
30 Dec 2003
Viewing 1 of 6 pages
View more
